• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

To date, there were limited studies available on myocardial infarction (MI), and
consequently, the outcomes of patients with type 1 myocardial infarction (T1MI) compared to …

Background Little is known about patients with cancer presenting with acute chest
discomfort to the emergency department (ED). Objectives The aim of this study was to …

Background Type 2 myocardial infarction (T2MI) related to a supply/demand imbalance of
coronary blood flow is common and associated with poor prognosis. Coronary artery …

Increasing observational and experimental trial data have shown that mental stress can lead
to an increase in adverse clinical cardiovascular events. Mental stress affects the heart by …

Myocardial infarction (MI) is an acute clinical manifestation ischaemic heart disease, which
is the leading cause of death worldwide. Infections also have an important burden …

Background Whilst it is known patients without standard modifiable cardiovascular risk
factors (SMuRF; hypertension, diabetes, hypercholesterolaemia, smoking) have worse …

Background Patients with gastrointestinal bleeding (GIB) are at an increased risk of
cardiovascular events and myocardial infarction (MI). Myocardial supply-demand mismatch …

Aims Large outcome trials have demonstrated cardiovascular benefits of selected glucagon-
like peptide-1 (GLP-1) receptor agonists. We examined coronary disease outcomes in the …

BACKGROUND: Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI)
differ with respect to demographics, comorbidities, treatments, and clinical outcomes …